| Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. | |
| | |
MedLine Citation:
|
PMID: 18295959 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Endometriosis and endometrial endometrioid carcinoma are both capable of invasion and metastasis, but their biological behavior is strikingly different. Matrix metalloproteinases (MMPs) and changes in adhesion molecules have a role in the pathogenesis of various physiological and pathological processes, as well as in the development of endometriosis and endometrioid endometrial carcinoma. We hypothesized that endometriosis, being a benign process, will show different MMPs and adhesion molecules expressions, compared to endometrioid endometrial carcinoma, a disease with potential of malignant behavior. STUDY DESIGN: We performed an immunohistochemical study to investigate expression of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), E-cadherin and beta-catenin in endometriosis, low-grade endometrial endometrioid carcinoma, and eutopic proliferative endometrium. Endometriotic tissues (n=15), low-grade endometrial endometrioid carcinomas (n=15), and unremarkable proliferative endometrium from women without endometriosis or carcinoma (n=10) were examined. RESULTS: Endometriotic tissues showed statistically significantly stronger staining for MMP-9 and reduced beta-catenin expression when compared with proliferative endometrium. Endometrial endometrioid carcinoma showed decreased E-cadherin expression in comparison with proliferative endometrium. MMP-2 and MMP-9, and E-cadherin expressions were significantly higher and beta-catenin expression was significantly lower in endometriosis as compared to endometrioid carcinoma. CONCLUSIONS: We suggest that increased MMPs and altered beta-catenin may play a role in the pathogenesis of endometriosis. Decreased E-cadherin may be important in the development of endometrial endometrioid carcinoma. The changes in MMPs, E-cadherin and beta-catenin differ in endometriosis from those in endometrioid carcinoma, an interesting finding in view of the fact that both these diseases are capable of invasion and metastasis, but have different biological behavior. |
| | |
Authors:
|
Ruthy Shaco-Levy; Shalom Sharabi; Daniel Benharroch; Benjamin Piura; Netta Sion-Vardy |
Related Documents
:
|
15473339 - Uterine body cancer mass screening at tokai university hospital. 10874569 - The endometrial effects of serms. 2202159 - Pathophysiology and management of endometrial hyperplasia and carcinoma. 18720479 - Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial ne... 18795309 - A case of oncocytic carcinoma of the endometrium. 8089639 - Endometrial pattern in long-term users of net-en. 20300449 - Personalizing her2-targeted therapy in metastatic breast cancer beyond her2 status: wha... 23354799 - Tubercular mastitis - a great masquerader. 16473549 - The usefulness of a multidisciplinary educational programme after breast cancer surgery... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2008-03-04 |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 139 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-08-01 Completed Date: 2008-10-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 226-32 Citation Subset: IM |
Affiliation:
|
Department of Pathology, Soroka University Medical Center and Faculty of Health Sciences, Beer-Sheva, Israel. rsl@bgu.ac.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cadherins
/
metabolism* Carcinoma, Endometrioid / metabolism, pathology Case-Control Studies Endometrial Neoplasms / metabolism*, pathology Endometriosis / metabolism*, pathology Endometrium / cytology, metabolism* Female Humans Immunohistochemistry Matrix Metalloproteinase 2 / metabolism* Matrix Metalloproteinase 9 / metabolism* beta Catenin / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Cadherins; 0/beta Catenin; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Defensiveness and anxiety predict frontal EEG asymmetry only in specific situational contexts.
Next Document: Mad2 binding is not sufficient for complete Cdc20 sequestering in mitotic transition control (an in ...